We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actavis Settles Celebrex Litigation with Pfizer, Aims For First-Filer Exclusivity
Actavis Settles Celebrex Litigation with Pfizer, Aims For First-Filer Exclusivity
Actavis and Pfizer say they have settled all patent litigation over the generic version of painkiller Celebrex, which may clear the way for Actavis to start marketing its version of the drug before the end of the year.